U.S. District Judge David Campbell of the District of Arizona is overseeing the trial, which began on April 21 and is set to ...
C.R. Bard developed an antimicrobial port catheter intended to reduce infection rates but never received FDA clearance.
Heterozygous Germline ATM Mutations Do Not Contribute to Radiation-Associated Malignancies After Hodgkin's Disease PURPOSE: To examine the safety, efficacy, costs, and impact on quality of life of ...
Interventional radiologist Darren Hurst said there’s no evidence a patient's catheter infection stemmed from his at-home ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results